Corey Davis, J.D., M.S.P.H., is deputy director of the Network’s Southeastern Region Office and  Director of the Harm Reduction Legal Project. Corey was previously a Senior Attorney at the National Health Law Program (NHeLP), where he helped to advance access to quality health care for low-income and underserved individuals. Before joining NHeLP Corey served as Employment Rights Attorney at Equality Advocates Pennsylvania, where he represented lesbian, gay, bisexual and transgender (LGBT) individuals before administrative commissions and in state and federal courts. He previously oversaw a street-based legal clinic sited at Philadelphia’s syringe exchange program.

Corey has served as chair of a county board of health, chair of the board of the North Carolina Harm Reduction Coalition, and vice-chair of the North Carolina Harm Public Health Foundation, among other positions. He is a recipient of the International AIDS Society’s Young Investigator Award andhas published extensively in the lay and academic press. Corey received his B.S. from the Indiana University of Pennsylvania, his M.S.P.H. from the University of North Carolina at Chapel Hill and his J.D. from Temple University. Corey is barred in Pennsylvania and New Jersey as well as various federal courts.

View a collection of research, resources and trainings produced by Corey below.

Articles & Resources

Dual Epidemics of COVID-19 and Overdose Highlight Impact of Structural Racism

Law & Policy InsightsCOVID-19Opioid Misuse and Overdose PreventionRacism as a Public Health Crisis

October 20, 2021
by Corey Davis

The United States remains in the grip of both COVID-19 and drug-related harm. Both are public health emergencies marked by tens of thousands of preventable deaths – and both disproportionately impact Black, Hispanic, Native, and other non-White people. Addressing the structural racism that drive inequality in access to economic opportunity, educational attainment, and other factors that ultimately drives health disparities must be a key public health priority – both during the dual COVID and overdose epidemics and beyond.  

Read more

Recent Federal Policy Changes Improve Buprenorphine Access, but X-Waiver Remains a Barrier for Opioid Use Disorder Treatment

Law & Policy InsightsHarm Reduction Legal ProjectOpioid Misuse and Overdose PreventionSubstance Use Prevention and Harm Reduction

October 20, 2021
by Corey Davis

The medications for opioid use disorder, methadone and buprenorphine, can reduce overdose deaths by over 50 percent. Unfortunately, many people who want to access these medications are unable to do so  because of federal and state legal restrictions, primarily the federal X-waiver, which a physician must obtain in order to prescribe these medications. While the requirement itself is statutory and can only be changed by Congress, the departments of Justice and Health and Human Services (HHS)  have a great deal of autonomy in determining its exact contours.

Read more

Substance Use Disorder (SUD)-Related Emergency Department Mandates

50-state surveyHarm Reduction Legal ProjectHarm Reduction Legal Project ResourcesOpioid Misuse and Overdose Prevention

October 19, 2021
by Corey Davis

We conducted a systematic legal review to determine the prevalence and characteristics of state laws that require some or all hospital emergency departments to create protocols to screen patients for substance use disorder as well as those that require that hospitals take specific actions when providing care to such individuals or individuals who have experienced an overdose.

View page

A Decade of Both Progress and Missed Opportunities to Reduce Drug-Related Harm

Law & Policy InsightsHarm Reduction Legal ProjectOpioid Misuse and Overdose PreventionSubstance Use Prevention and Harm Reduction

June 16, 2021
by Corey Davis

Over the past ten years, there have been important and lifesaving efforts to address drug related harm. All states have passed laws increasing access to the overdose reversal medication naloxone and nearly all have passed overdose Good Samaritan laws, and dedicated advocates have succeeded in legalizing syringe services programs in several states. Unfortunately, law still overwhelmingly works to increase, rather than decrease, risks to people who use drugs. In this commentary, Corey Davis, director of the Network’s Harm Reduction Legal Project, reflects on efforts to address the opioid epidemic and why additional systemic change is needed. Read more.

Read more

Equitable Rebuilding from COVID-19: Ensuring Quality Care for Vulnerable Populations

WebinarsCOVID-19COVID-19 and Health EquityMental Health and Well-BeingOpioid Misuse and Overdose PreventionTelehealth

May 11, 2021
by Amy Lieberman, Corey Davis and Jill Krueger

In this webinar, presenters will describe the nature of the laws being announced from the judicial bench or proposed in state legislatures, the process by which they are being formulated in every level and branch of government, and the principles that should guide legal developments as we seek to balance the facts, expert opinion, and civic participation, as well as guard against harmful unforeseen consequences.

View page

Access to Treatment for Individuals with Opioid Use Disorder

GuidanceHarm Reduction Legal Project ResourcesOpioid Misuse and Overdose Prevention

April 21, 2021
by Amy Lieberman and Corey Davis

The Network has joined with public health law partners to produce a new report, COVID-19 Policy Playbook: Legal Recommendations for a Safer, More Equitable Future, examining policy challenges and opportunities in light of the pandemic. In this Q&A, the Network’s Corey Davis and Amy Lieberman discuss some of the key elements in the chapter they co-authored for the report including the positive impact of opioid use disorder (OUD) treatment, recent changes to increase access to that treatment, and recommendations for permanently reducing legislative and regulatory barriers to effective, evidence-based interventions for OUD.

View page

American Rescue Plan Act Provides Opportunity for Syringe Access

Law & Policy InsightsHarm Reduction Legal ProjectSubstance Use Prevention and Harm Reduction

March 30, 2021
by Corey Davis

President Biden signed the American Rescue Plan Act of 2021 (ARPA) into law on March 11, 2021. While most media attention focused on its headline provisions, including $1,400 stimulus checks for many individuals, $350 billion in aid to state, local, and tribal governments, and expansions in the Earned Income Tax Credit and child tax credit, the Act also contains historic assistance for harm reduction programs.

Read more

Ensuring Access to Clean Needles Can Save Lives, but Legal Barriers Persist

Law & Policy InsightsHarm Reduction Legal ProjectHarm Reduction Legal Project ResourcesOpioid Misuse and Overdose PreventionSubstance Use Prevention and Harm Reduction

February 5, 2021
by Amy Lieberman and Corey Davis

The United States continues to experience an unprecedented level of drug-related harm. While the failure to prevent this harm is most notable in the number of overdose deaths, which are now at their highest level on record, it is evident in other areas as well. Of particular importance from a policy perspective, bloodborne disease infections related to syringe sharing are also on the rise, with recent outbreaks in Kentucky, Massachusetts, and Indiana, among other states. Cases of infective endocarditis, which is caused largely by unsafe injection, are increasing as well.

Read more